- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Tapentadol – March 2011
Tapentadol, tablet, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg (as hydrochloride) (sustained release), Palexia SR®
Last updated
1 July 2011
